FDA-cleared profile

Aplio i900/i800/i700 Diagnostic Ultrasound System, Software V6.5

Canon Medical Systems Corporation · Ultrasound · FDA-cleared (510(k))

Authorized purpose: Aplio i900/i800/i700 software V6.5 is a mobile diagnostic ultrasound system for trained physicians or legally qualified users to visualize structures and dynamic processes and provide diagnostic images across fetal, abdominal, pediatric, small-organ, cephalic, cardiac, vascular, transesophageal, musculoskeletal, laparoscopic, and thoracic or pleural applications using B-mode, Doppler, elastography, and related ultrasound modes.

Clinical role
Supports diagnostic ultrasound acquisition and review with B-mode, M-mode, Doppler, tissue harmonic, shear-wave, elastography, attenuation, and related imaging modes. Software V6.5 also adds Tissue Shift Tracking and workflow features for cardiac, breast, lung, abdominal, and shared-image review.
Images and patients
Ultrasound · Multi-region
Key limitation
Keep in mind: This system is suitable for use in hospital and clinical settings by physicians or legally qualified persons who have received the appropriate training. No clinical studies were required to demonstrate safety and efficacy of the Aplio i900/i800/i700, V6.5 systems.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Aplio i900/i800/i700 software V6.5 is a mobile diagnostic ultrasound system for trained physicians or legally qualified users to visualize structures and dynamic processes and provide diagnostic images across fetal, abdominal, pediatric, small-organ, cephalic, cardiac, vascular, transesophageal, musculoskeletal, laparoscopic, and thoracic or pleural applications using B-mode, Doppler, elastography, and related ultrasound modes.
  • Which images or clinical context are in scope?Modality: Ultrasound Anatomy or clinical context: Multi-region Input: The Aplio i900 Model TUS-AI900, Aplio i800 Model TUS-AI800 and Aplio i700 Model TUS-AI700, V6.5 are mobile diagnostic ultrasound systems. These systems employ a wide array of probes including flat linear array, convex, and sector array with frequency ranges between approximately 2MHz to 30 MHz.
  • Who uses it?Intended users: Trained physicians or other legally qualified healthcare professionals.
  • What does the software produce?Output: Diagnostic ultrasound images, Doppler and quantitative measurements, elastography and attenuation displays, and feature-specific analysis results for qualified-user interpretation. Supported features include automated initial contour tracing for two-dimensional wall-motion tracking and full-assist automatic ejection-fraction analysis.
  • What is its most important limitation?Key limitation: This system is suitable for use in hospital and clinical settings by physicians or legally qualified persons who have received the appropriate training. No clinical studies were required to demonstrate safety and efficacy of the Aplio i900/i800/i700, V6.5 systems.

Clinical takeaway. Clinical role: Aplio i900/i800/i700 software V6.5 is a mobile diagnostic ultrasound system for trained physicians or legally qualified users to visualize structures and dynamic processes and provide diagnostic images across fetal, abdominal, pediatric, small-organ, cephalic, cardiac, vascular, transesophageal, musculoskeletal, laparoscopic, and thoracic or pleural applications using B-mode, Doppler, elastography, and related ultrasound modes.

Evidence takeaway. Evidence from the reviewed source record: FDA-reviewed support consists of manufacturer verification and validation with phantoms, test data, and volunteer data. No independent clinical outcomes study is reported in the 510(k) summary.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Aplio i900/i800/i700 software V6.5 is a mobile diagnostic ultrasound system for trained physicians or legally qualified users to visualize structures and dynamic processes and provide diagnostic images across fetal, abdominal, pediatric, small-organ, cephalic, cardiac, vascular, transesophageal, musculoskeletal, laparoscopic, and thoracic or pleural applications using B-mode, Doppler, elastography, and related ultrasound modes.
  • Exact FDA submission
  • Checked 2026-09-19

Clinical-use display mirrors the exact FDA-supported purpose reconciled from the decision-summary packet.

Workflow role
Supports diagnostic ultrasound acquisition and review with B-mode, M-mode, Doppler, tissue harmonic, shear-wave, elastography, attenuation, and related imaging modes. Software V6.5 also adds Tissue Shift Tracking and workflow features for cardiac, breast, lung, abdominal, and shared-image review.
  • Exact FDA submission
  • Checked 2026-09-02
Required input
The Aplio i900 Model TUS-AI900, Aplio i800 Model TUS-AI800 and Aplio i700 Model TUS-AI700, V6.5 are mobile diagnostic ultrasound systems. These systems employ a wide array of probes including flat linear array, convex, and sector array with frequency ranges between approximately 2MHz to 30 MHz.
  • Exact FDA submission
  • Checked 2026-09-19

The exact packet establishes the mobile systems and probe/frequency scope; it does not establish the dossier's stored-raw-data and external-connection input wording.

Output and clinician action
Diagnostic ultrasound images, Doppler and quantitative measurements, elastography and attenuation displays, and feature-specific analysis results for qualified-user interpretation. Supported features include automated initial contour tracing for two-dimensional wall-motion tracking and full-assist automatic ejection-fraction analysis.
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

Care setting
Hospital and clinical environments where diagnostic ultrasound is performed by trained or legally qualified personnel.
  • Exact FDA submission
  • Checked 2026-09-02
Intended users
Trained physicians or other legally qualified healthcare professionals.
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

Limitations
This system is suitable for use in hospital and clinical settings by physicians or legally qualified persons who have received the appropriate training. No clinical studies were required to demonstrate safety and efficacy of the Aplio i900/i800/i700, V6.5 systems.
  • Exact FDA submission
  • Checked 2026-09-19

The direct packet establishes the user/setting boundary and testing boundary without the dossier's configuration-dependent limitation.

Evidence summary
FDA-reviewed support consists of manufacturer verification and validation with phantoms, test data, and volunteer data. No independent clinical outcomes study is reported in the 510(k) summary.
  • Exact FDA submission
  • Checked 2026-09-02

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
FDA-reviewed support consists of manufacturer verification and validation with phantoms, test data, and volunteer data. No independent clinical outcomes study is reported in the 510(k) summary.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-02
Reported sensitivity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

Reported specificity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

K212333 software V6.5 verification and validation

  • DesignManufacturer bench and software verification and validation using phantoms, test data, and volunteer data
  • PopulationAplio i900, i800, and i700 systems and the V6.5 feature set; volunteer count and composition were not reported in the 510(k) summary
  • Scopeexact submission
  • Tested versionAplio i900, i800, and i700 software V6.5
  • IndependenceSponsor or vendor study

K212333

Regulatory verification and validation evidence; it does not establish comparative clinical outcomes or site-specific performance.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
FDA recall Z-0198-2023 includes Canon Aplio i700, i800, and i900 systems. If a Stress Echo protocol is not manually terminated, a subsequent examination may fail to save images or may assign images to the previous patient, potentially delaying treatment. FDA lists the recall as open and classified.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-04

Each published event was manually matched to the exact FDA submission and affected product or version; a recall does not establish an AI-algorithm defect or current site exposure unless the event states that scope.

recall: Z-0198-2023

Open, Classified

2022-11-08

Exact i-series model match. The FDA recall record does not identify software V6.5 and also includes Aplio a-series models, so confirm the affected system and version locally.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: The Aplio i900 Model TUS-AI900, Aplio i800 Model TUS-AI800 and Aplio i700 Model TUS-AI700, V6.5 are mobile diagnostic ultrasound systems. These systems employ a wide array of probes including flat linear array, convex, and sector array with frequency ranges between approximately 2MHz to 30 MHz.

    Scope: Exact FDA submission. The exact packet establishes the mobile systems and probe/frequency scope; it does not establish the dossier's stored-raw-data and external-connection input wording.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-19 · FDA K212333: Aplio i900/i800/i700 Diagnostic Ultrasound System, Software V6.5

  2. Routing

    Source context, not route validation: Software V6.5 can transfer DICOM data through Tricefy Access, store raw data on network-attached storage, and share deidentified images through Apligate or Apligate Soft. Canon also publishes IHE integration statements for Aplio i700, i800, and i900 software V6.0 or later.

    Scope: Exact FDA submission. Confirm the installed IHE statement, DICOM services, network-storage configuration, deidentification behavior, and cloud transfer terms for the exact local software build.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-02 · FDA K212333: Aplio i900/i800/i700 Diagnostic Ultrasound System, Software V6.5 · IHE integration statements for current Canon ultrasound products

  3. AI processing

    Source context, not route validation: On-premises mobile Aplio i900, i800, or i700 ultrasound system running software V6.5, with optional site-network and external-service connections for supported data-transfer workflows.

    Scope: Exact FDA submission.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-02 · FDA K212333: Aplio i900/i800/i700 Diagnostic Ultrasound System, Software V6.5

  4. Returned objects

    Source context, not route validation: Diagnostic ultrasound images, Doppler and quantitative measurements, elastography and attenuation displays, and feature-specific analysis results for qualified-user interpretation. Supported features include automated initial contour tracing for two-dimensional wall-motion tracking and full-assist automatic ejection-fraction analysis.

    Scope: Exact FDA submission. Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-19 · FDA K212333: Aplio i900/i800/i700 Diagnostic Ultrasound System, Software V6.5

  5. Viewer/worklist/report

    Unresolved route: Diagnostic ultrasound images, Doppler and quantitative measurements, elastography and attenuation displays, and feature-specific analysis results for qualified-user interpretation. Supported features include automated initial contour tracing for two-dimensional wall-motion tracking and full-assist automatic ejection-fraction analysis.

    Scope: Exact FDA submission. Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-19 · FDA K212333: Aplio i900/i800/i700 Diagnostic Ultrasound System, Software V6.5

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
On-premises mobile Aplio i900, i800, or i700 ultrasound system running software V6.5, with optional site-network and external-service connections for supported data-transfer workflows.
  • Exact FDA submission
  • Checked 2026-09-02
Integration
Software V6.5 can transfer DICOM data through Tricefy Access, store raw data on network-attached storage, and share deidentified images through Apligate or Apligate Soft. Canon also publishes IHE integration statements for Aplio i700, i800, and i900 software V6.0 or later.
  • Exact FDA submission
  • Checked 2026-09-02

Confirm the installed IHE statement, DICOM services, network-storage configuration, deidentification behavior, and cloud transfer terms for the exact local software build.

Security
Canon Medical's cybersecurity page states that Canon imaging systems follow a software development life cycle governed by the NIST 800-53 Risk Management Framework adhering to Defense Health Agency certification requirements; FIPS 140-2 certified cipher standards; deny-all firewall configuration and near-real-time SIEM syslog export as premium offerings; a dedicated cybersecurity risk management team for threat intelligence monitoring, advisories and incident response; and published OS and third-party update policies. Vendor statement; no certification or test report was read.
  • Vendor-wide
  • Checked 2026-10-26

Vendor statement, not an attestation. Identity bridge: the page is on us.medical.canon, Canon Medical's own site (Canon Medical Systems USA), and describes Canon Medical imaging devices generally; the FDA applicant is Canon Medical Systems Corporation, named in the corporate name-change press release on the same domain. Regional page with general device claims; exact-release scope is not established.

Supported ultrasound modes and probes

Supports compatible linear, convex, and sector probes at approximately 2 to 30 MHz and B-mode, M-mode, continuous-wave, color, pulsed-wave, power and combination Doppler, tissue harmonic, shear-wave, elastography, attenuation, and related modes.

exact submission · checked 2026-09-02

Confirm each probe, option, and clinical preset on the purchased configuration.

DICOM and network workflows

The FDA summary describes DICOM transfer through Tricefy Access, raw-data storage on network-attached storage, and deidentified image sharing through Apligate or Apligate Soft.

exact submission · checked 2026-09-02

Validate local routing, firewall rules, identity handling, storage capacity, retention, and external-service terms before use.

IHE integration documentation

Canon's current interoperability page lists IHE integration statements for Aplio i700, i800, and i900 software V6.0 or later.

exact product version · checked 2026-09-02

Obtain and test the statement corresponding to the exact installed model and software build.

Deployment model

Mobile, on-premises diagnostic ultrasound console with optional site-network and external-service connectivity.

exact submission · checked 2026-09-02

Site preparation, cybersecurity controls, service access, software-update policy, training, and downtime planning require current vendor documentation.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K212333
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
Ultrasound
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-19

The exact device name and common name identify a diagnostic ultrasound system; the active dossier has no modality fact. Controlled directory display reconciled from exact FDA wording: Diagnostic Ultrasound System. -> Ultrasound.

Anatomy
Multi-region
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2022-01-24
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-04Last searched
23Fields reviewed
10Source classes checked
20Screened PubMed leads
10Screened trial leads
0Unreviewed FDA recall leads

The refreshed discovery snapshot contains 20 PubMed and 10 ClinicalTrials.gov candidate records. Discovery metadata alone does not establish exact tested-product, version, population, and endpoint applicability, so all candidates remain quarantined and none was promoted. The current discovery snapshot contains 20 PubMed and 10 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. 1 FDA recall candidate was manually reviewed: 1 published and 0 rejected as a neighboring or otherwise inapplicable version. Native FDA recall identifiers produced 1 postmarket candidate record; 1 has been reviewed (1 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, fda device recall, vendor interoperability, fda decision summary packet, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-10-27 - Exact FDA submission

    No public price or quote for the exact K212333 configuration was established in this review.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission

    Bounded web search on 2026-10-26 (query: "Canon Aplio reimbursement CPT Medicare"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. This records what was found, not that none exists.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-10-27 - Exact FDA submission

    Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.

  • Monitoring: Not verified - checked 2026-10-27 - Exact FDA submission

    Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.

8 sources - 3 history items

Source ledger

  1. FDA K212333: Aplio i900/i800/i700 Diagnostic Ultrasound System, Software V6.5

    U.S. Food and Drug Administration - Published 2022-01-24 - Accessed 2026-09-19

    Scope: purpose, anatomy, intendedUsers, output, modality, input, limitations, evidenceSummary, clinicalUse

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. FDA recall Z-0198-2023: Canon Aplio ultrasound system, Model: Aplio i900 TUS-AI900, Aplio i800 TUS-AI800, Aplio i700 TUS-AI700, Aplio a550 CUS-AA550, Aplio a450 CUS-AA450

    U.S. Food and Drug Administration - Published 2022-11-08 - Accessed 2026-09-04

    Scope: postmarketSafety, affectedProduct, recallStatus, correctiveAction

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. IHE integration statements for current Canon ultrasound products

    Canon Medical Systems Corporation - Accessed 2026-09-02

    Scope: integration, implementationCapabilities

  8. Canon Medical: Medical Imaging Cybersecurity

    Canon Medical Systems USA - Accessed 2026-10-26

    Scope: security

Research history

  1. K212333 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K251963

LOGIQ E10s

Ge Medical Systems Ultrasound and Primary Care Diagnostics

Authorized purpose: LOGIQ E10s is a general-purpose diagnostic ultrasound system supporting the labeled adult, pediatric, cardiac, vascular, abdominal, obstetric, small-organ, musculoskeletal, urologic, and procedural applications.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2025-10-29
FDA-cleared K251985

LOGIQ E10

Ge Medical Systems Ultrasound and Primary Care Diagnostics

Authorized purpose: LOGIQ E10 is a general diagnostic ultrasound system for qualified users across fetal and obstetric, abdominal, gynecologic, pediatric, small-organ, breast, cardiac, vascular, musculoskeletal, urologic, transrectal, transvaginal, transesophageal, and intraoperative applications.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2025-10-29
FDA-cleared K250999

V8 Diagnostic Ultrasound System; cV8 Diagnostic Ultrasound System; V7 Diagnostic Ultrasound System; cV7 Diagnostic Ultrasound System; V6 Diagnostic Ultrasound System; cV6 Diagnostic Ultrasound System; V5 Diagnostic Ultrasound System; cV5 Diagnostic Ultrasound System; V4 Diagnostic Ultrasound System; cV4 Diagnostic Ultrasound System

Samsung Medison Co., Ltd.

Authorized purpose: The Samsung V-family diagnostic ultrasound systems support fetal and obstetric, abdominal, gynecologic, pediatric, small-organ, cephalic, cardiac, thoracic, vascular, musculoskeletal, urologic, transrectal, transvaginal, transesophageal, intraoperative, and dermatologic applications where labeled.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2025-07-18

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history